# Pediatric Head Lice Study Product Comparison

> **NCT02213055** · PHASE2 · COMPLETED · sponsor: **Hackensack Meridian Health** · enrollment: 97 (actual)

## Conditions studied

- Head Lice

## Interventions

- **DRUG:** LICEMD
- **DRUG:** Standard Head lice product

## Key facts

- **NCT ID:** NCT02213055
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2016-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02213055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02213055, "Pediatric Head Lice Study Product Comparison". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02213055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
